Ionic homeostasis in brain conditioning by Cuomo, Ornella et al.
REVIEW
published: 10 August 2015
doi: 10.3389/fnins.2015.00277
Frontiers in Neuroscience | www.frontiersin.org 1 August 2015 | Volume 9 | Article 277
Edited by:
Mark P. Burns,
Georgetown University Medical
Center, USA
Reviewed by:
Zhihui Yang,
University of Florida, USA
Patrick A. Forcelli,
Georgetown University, USA
*Correspondence:
Giuseppe Pignataro,
Division of Pharmacology, Department
of Neuroscience, Reproductive and
Dentistry Sciences, School of
Medicine, “Federico II” University of
Naples, Via Pansini 5,
80131 Naples, Italy
gpignata@unina.it
Specialty section:
This article was submitted to
Neurodegeneration,
a section of the journal
Frontiers in Neuroscience
Received: 26 March 2015
Accepted: 23 July 2015
Published: 10 August 2015
Citation:
Cuomo O, Vinciguerra A, Cerullo P,
Anzilotti S, Brancaccio P, Bilo L,
Scorziello A, Molinaro P, Di Renzo G
and Pignataro G (2015) Ionic
homeostasis in brain conditioning.
Front. Neurosci. 9:277.
doi: 10.3389/fnins.2015.00277
Ionic homeostasis in brain
conditioning
Ornella Cuomo 1, Antonio Vinciguerra 1, Pierpaolo Cerullo 1, Serenella Anzilotti 2,
Paola Brancaccio 1, Leonilda Bilo 3, Antonella Scorziello 1, Pasquale Molinaro 1,
Gianfranco Di Renzo 1 and Giuseppe Pignataro 1*
1Division of Pharmacology, Department of Neuroscience, Reproductive and Dentistry Sciences, School of Medicine,
Federico II University of Naples, Naples, Italy, 2 SDN Istituto di Ricerca Diagnostica e Nucleare, Naples, Italy, 3Division of
Neurology, Department of Neuroscience, Reproductive and Dentistry Sciences, School of Medicine, Federico II University of
Naples, Naples, Italy
Most of the current focus on developing neuroprotective therapies is aimed at preventing
neuronal death. However, these approaches have not been successful despite many
years of clinical trials mainly because the numerous side effects observed in humans
and absent in animals used at preclinical level. Recently, the research in this field
aims to overcome this problem by developing strategies which induce, mimic, or
boost endogenous protective responses and thus do not interfere with physiological
neurotransmission. Preconditioning is a protective strategy in which a subliminal stimulus
is applied before a subsequent harmful stimulus, thus inducing a state of tolerance in
which the injury inflicted by the challenge is mitigated. Tolerance may be observed in
ischemia, seizure, and infection. Since it requires protein synthesis, it confers delayed
and temporary neuroprotection, taking hours to develop, with a pick at 1–3 days. A
new promising approach for neuroprotection derives from post-conditioning, in which
neuroprotection is achieved by a modified reperfusion subsequent to a prolonged
ischemic episode. Many pathways have been proposed as plausible mechanisms to
explain the neuroprotection offered by preconditioning and post-conditioning. Although
the mechanisms through which these two endogenous protective strategies exert their
effects are not yet fully understood, recent evidence highlights that the maintenance of
ionic homeostasis plays a key role in propagating these neuroprotective phenomena. The
present article will review the role of protein transporters and ionic channels involved in
the control of ionic homeostasis in the neuroprotective effect of ischemic preconditioning
and post-conditioning in adult brain, with particular regards to the Na+/Ca2+ exchangers
(NCX), the plasma membrane Ca2+-ATPase (PMCA), the Na+/H+ exchange (NHE),
the Na+/K+/2Cl− cotransport (NKCC) and the acid-sensing cation channels (ASIC).
Ischemic stroke is the third leading cause of death and disability. Up until now, all
clinical trials testing potential stroke neuroprotectants failed. For this reason attention of
researchers has been focusing on the identification of brain endogenous neuroprotective
mechanisms activated after cerebral ischemia. In this context, ischemic preconditioning
and ischemic post-conditioning represent two neuroprotecive strategies to investigate in
order to identify new molecular target to reduce the ischemic damage.
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Ischemic Preconditioning
The concept of ischemic preconditioning was introduced first in
the heart (Murry et al., 1986) and later on in the brain (Murry
et al., 1986; Schurr et al., 1986). Ischemic preconditioning is
neuroprotective strategy in which a subliminal stimulus is applied
before a subsequent harmful ischemia (Kirino, 2002; Dirnagl
et al., 2003; Gidday, 2006). The state of tolerance mediated by
this strategy is composed of two phases of neuroprotection.
The first phase, named rapid or acute preconditioning (Perez-
Pinzon et al., 1997), starts 3–5min after the preconditioning
stimulus and ends 1 h later and is due to rapid post-translational
protein modifications (Barone et al., 1998; Meller et al., 2006).
The second phase, named delayed preconditioning (Perez-
Pinzon et al., 1997), starts 2–3 days after preconditioning
and ends 1 week later and mainly involves de novo protein
synthesis (Barone et al., 1998; Dirnagl et al., 2003; Meller et al.,
2005).
Mechanisms Involved in Ischemic
Preconditioning Neuroprotection
The molecular mechanisms underlying ischemic tolerance are
not yet fully understood because of its extreme complexity,
involving many signaling pathways and alterations in gene
expression. Several studies have investigated the signaling
cascades and key molecules both in in vitro and in vivo models
of ischemic preconditioning. Most of the stressors induce both
rapid and delayed tolerance. As recently reviewed (Obrenovitch,
2008), the features of ischemic tolerance partially are similar to
naturally occurring adaptive mechanisms, including at cellular
levels:
1. Alterations in cellular energy metabolism: preconditioning
preserves mitochondrial function (Dave et al., 2001; Racay
et al., 2007) and mediates an increase in expression of genes
playing a role in energy metabolism.
2. Preservation of mitochondrial membrane potential:
preconditioning preserves respiratory complexes,
mitochondrial oxidative phosphorylation and antioxidant
enzymes such as superoxide dismutases (SODs), catalase,
glutathione peroxidase, and thioredoxin system (Danielisová
et al., 2006; Racay et al., 2007).
3. Modulation of neuronal excitotoxicity: preconditioning
mediates a shift to inhibitory neurotransmission, suppressing
glutamate release, downregulating AMPA and NMDA
receptors, and glial glutamate transporters, increasing GABA
release and GABA-A receptors expression (Dave et al., 2005).
4. Suppression of cell death and apoptotic mechanisms:
preconditioning reduces the release of cytochrome c, inhibits
caspases, and proapoptotic genes, and activates survival
pathways such as serine/threonine activated kinases (Akt)
and extracellular signal-regulated kinases (ERK) and trophic
factors (Lehotský et al., 2009).
5. Activation of the mechanisms mediating DNA repair and
plasticity by increasing the activity nerve growth factor (NGF)
and brain-derived neurotrophic factor (BDNF) (Gidday, 2006;
Lehotský et al., 2009).
6. Reduction of inflammatory response: preconditioning
activates Toll-like receptor, suppresses induced
proinflammatory cytokines (TNFs) and activates transcription
nuclear factor κB (NFκB) (Gidday, 2006).
7. Cerebrovascular adaptation by vascular remodeling:
preconditioning activates vascular endothelial growth
factors (VEGF), erythropoietin and heme oxygenase 1 as
targets of hypoxia inducing factor 1α (HIF-1α). The blood–
brain barrier was preserved thanks to the reduced activity
of matrix metalloproteinases and cell adhesion molecules
(Gidday, 2006).
8. Improved capacity to preserve cellular ionic and pH
homeostasis: preconditioning regulates expression and
activity of ion transport systems (Ca2+-ATPase, acid-sensing
ion channels, Na+/H+ exchange, Na+/K+/2Cl− cotransport
and Na+/Ca2+ exchanger) and transporters for metabolites.
Ischemic Post-conditioning
Unlike ischemic preconditioning, ischemic post-conditioning is
a relatively novel neuroprotective strategy (Zhao et al., 2006;
Pignataro et al., 2008). Rapid revascularization of the occluded
vessels represent one of the most effective approaches currently
used for the treatment of acute ischemic stroke. However, during
the early reperfusion phase an increase in reactive oxygen species
and intracellular free Ca2+ may occur, thus leading to additional
injury (Kuroda and Siesjö, 1997). Ischemic post-conditioning
is realized by applying brief interruptions of reperfusion after
ischemia. That a protocol of cycles of brief reperfusion followed
by re-occlusion was able to reduce the ischemic damage was
first demonstrated during cardiac ischemia (Zhao et al., 2003).
More recently, it has been demonstrated that ischemic post-
conditioning induces neuroprotection also in a rat hippocampal
slice model of cerebral ischemia (Scartabelli et al., 2008), in
rodent models of spinal cord injury (Jiang et al., 2006), and in
models of focal (Zhao et al., 2006; Pignataro et al., 2008, 2013b;
Xing et al., 2008), and global ischemia (Pateliya et al., 2008; Wang
et al., 2008).
Mechanisms Involved in Ischemic
Post-conditioning Neuroprotection
At present a few information are available about the mechanisms
involved in the neuroprotection mediated by ischemic post-
conditioning. Since post-conditioning is applied after the
ischemic injury, the changes observed in the brain have to
be ascribed to the combined effects of post-conditioning and
stroke, rather than the effect of the post-conditioning only.
Thus, it is difficult to sunder the protective mechanisms of post-
conditioning from the consequences of its protection. However,
up until now, many mechanisms have been suggested (Zhao,
2009), such as:
1. Reduction of hyperemia consequent to the reperfusion,
that may be accompanied other toxic events, such as the
production of free radicals, loss of blood–brain barrier
integrity, and activation of inflammation cascade (Schaller and
Graf, 2004).
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2. Blocking of apoptosis. Ischemic post-conditioning reduced
ROS production (Zhao et al., 2006), attenuates lipid
peroxidate levels (Xing et al., 2008) and increased the activities
of antioxidant enzymes, such as superoxide dismutase and
catalase (Danielisová et al., 2006). Furthermore, rapid post-
conditioning reduced the release of cytochrome c from
the mitochondria to the cytosol, a critical cascade for the
induction of apoptosis, thus suggesting that post-conditioning
may reduce ischemic injury by blocking apoptosis (Zhao et al.,
2012).
3. Inhibition of inflammation. Rapid post-conditioning inhibits
inflammation after stroke. Indeed, rapid post-conditioning
inhibits myeloperoxidase activity, an indicator of leukocyte
accumulation (Xing et al., 2008), attenuates the expressions of
IL-1β, TNF-α, and the ICAM-1 protein expression (Xing et al.,
2008).
4. Activation of Akt Pathway. In agreement with previous
studies demonstrating that the Akt pathway promotes
neuronal survival after stroke (Zhao et al., 2006), rapid
post-conditioning increases Akt phosphorylation and Akt
activity (Gao et al., 2008; Pignataro et al., 2008). Furthermore,
the protection mediated by rapid post-conditioning was
prevented by Akt inhibition (Gao et al., 2008; Pignataro et al.,
2008) and abolished the protective effect post-conditioning
in hippocampal slice cultures (Scartabelli et al., 2008),
overall, ischemic post-conditioning exerts its neuroprotective
effectiveness also through Akt activation.
5. Cellular ionic homeostasis and energy metabolism. Post-
conditioning-mediated neuroprotection is correlated to the
maintainance of ionic homeostasis occurring by modulating
expression and activity of several proteins involved in ionic
homeostasis, some of which will be treated below (Figure 1,
Table 1).
Brain Ionic Transporters during Ischemic
Conditioning
Ischemic brain conditioning activates intracellular biological
responses to a potential lethal insult; therefore it is predictable
that organs reinforce their tolerance when exposed to a sublethal
insult prior or after a harmful episode of ischemia by increasing
energy metabolism or delaying anoxic depolarization after the
onset of the subsequent ischemic insult (Stenzel-Poore et al.,
2003; Pignataro et al., 2008, 2009). Indeed, an impairment
in the activity of voltage-gated potassium channels has been
observed in cortical neurons exposed to a brief non-injurious
oxygen and glucose deprivation (OGD). Moreover, it has
been demonstrated that ischemic conditioning prevented the
inhibition of Na+/K+-ATPase activity after brain ischemia in
hippocampal and cortical neurons of rats subjected to global
forebrain ischemia. Instead, in vivo experiments in gerbils
showed that both Ca2+-ATPase activity and mitochondrial
calcium internalization increased in CA1 hippocampal neurons
exposed to preconditioning (Ohta et al., 1996). Accordingly,
in hippocampal neurons obtained from preconditioned gerbils
[Ca2+]i increased after anoxic and aglycemic episodes whereas
this increase was inhibited in ischemic-tolerant animals
(Shimazaki et al., 1998). The molecular mechanisms of this
phenomenon are still under investigation. An explanation may
be the increase in the expression of the plasma membrane
calcium ATPase 1 (PMCA-1) as recently demonstrated (Kato
et al., 2005). Moreover, many evidence support the idea that
other transporters are involved in the protection mediated
by brain conditioning. In this regard, a key role is exerted by
the sodium calcium exchanger (NCX), in fact its expression
was reduced during cerebral ischemia (Pignataro et al., 2004;
Boscia et al., 2006). More important, NCX downregulation
was prevented when rats were subjected either to ischemic
preconditioning or post-conditioning (Pignataro et al., 2013a).
In addition Na+/H+ exchanger and Na+/K+/2Cl− cotransporter
are critical ion transporters in the context of cerebral ischemia,
as they contribute to the regulation of intracellular pH and cell
volume (Pedersen, 2006). Finally, acid-sensing cation channels
(ASIC) have also been studied during ischemic conditions
since they represent key targets in many different aspects of
acidosis, a condition that occurs during ischemic stroke. Brain
preconditioning as an adaptive response to stroke requires in
particular new protein transcription and translation; giving
that HIF-1–dependent transcription is being clearly common
in activating pathways of several exchangers/transporters/ionic
channels involved in stroke, scientific community has assigned
a key role to HIF-1α, as a master transcriptional regulator
of cellular and developmental response to hypoxia. In effect
stable HIF-1 can bind to its heterodimeric partner HIF-1β,
and together these proteins, once stabilized during hypoxic-
ischemic conditions, can act in the nucleus to transactivate
genes involved in adaptation to hypoxic-ischemic stress.
HIF represents the “hyphen” that definitely binds to each
other all the different mechanisms converging on the same
signaling cascade, responsible for the homeostatic regulation
in protected brain (Ratan et al., 2004). In the light of these
premises, the present article will review the main role of protein
transporters and exchangers controlling ionic homeostasis in
the neuroprotective effect of ischemic preconditioning and
post-conditioning, with particular regards to the Na+/Ca2+
exchangers (NCX), the plasma membrane Ca2+-ATPase
(PMCA), the Na+/H+ exchange (NHE), the Na+/K+/2Cl−
cotransport (NKCC) and the acid-sensing cation channels
(ASIC).
Role of Na+/H+ Exchange (NHE) and
Na+/K+/2Cl− Cotransport (NKCC) In Brain
Conditioning
The ubiquitous plasma membrane Na+/H+ exchanger is protein
highly conserved across vertebrate species and characterized as
a major membrane transporter involved in the regulation of
cellular pH and volume in the nephron of the kidney. Specifically
it is present in the intercalary cells of the collecting duct
(Pedersen, 2006). The Na+/K+/2Cl− cotransporter (NKCC) is a
protein that aids in the active transport of sodium, potassium,
and chloride into and out of cells; it is widely distributed
throughout the body and it has important functions in organs
that secrete fluids. NKCC2 is found specifically in the kidney,
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FIGURE 1 | Schematic representation of the ionic exchangers/transporters involved in the neuroprotection mediated by ischemic preconditioning and
post-conditioning.
TABLE 1 | Role of ionic exchangers/transporters during pre-and post-conditioning.
Ionic exchanger/
Transporter
Role during preconditioning Role during post-conditioning References
Na+/K+/2CI−
Cotransport (NK
CC)
Neuroprotective role: Activation of
NKCC participates in the protection
mediated by ischemic cardiac
preconditioning
Neuroprotective role: Activation of
NKCC1 mimiks an in vitro
post-conditioning
Schaefer et al., 1995;
Yang et al., 2013
Na+/H+
Exchange (NHE)
Neurodegenerative role: NHE inhibition
delays pH recovery thus mediating
protection
Neurodegenerative role: NHE inhibition
delays pH recovery thus mediating
protection
Shipolini et al., 1997;
Goldberg et al., 2002
ASIC Neurodegenerative role: ASIC
expression decrease during conditioning
Neurodegenerative role: ASIC
expression decrease during conditioning
Pignataro et al., 2011a
NCX Neuroprotective role: NCX expression
increase during conditioning and its
inhibition or silencing prevents
neuroprotection
Neuroprotective role: NCX expression
increase during conditioning and its
inhibition or silencing prevents
neuroprotection
Pignataro et al., 2011b,
2012
PMCA Neuroprotective role: PM CA 1 is
increased in the hippocampus following
preconditioning
Role not known Shimazaki et al., 1998
where it serves to extract sodium, potassium, and chloride from
the urine so that they can be reabsorbed into the blood (Haas,
1994).
Na+/H+ exchanger and Na+/K+/2Cl− cotransporter are
critical ion transporters in the context of cerebral ischemia, as
they contribute to the regulation of intracellular pH and cell
volume (Pedersen, 2006). In particular, while the mammalian
NHE is an integral membrane transport protein that mediates an
electroneutral 1:1 exchange of intracellular H+ for extracellular
Na+ (Xia et al., 2003), the electroneutral NKCC contransporter
mediates the influx of Na+, K+, and Cl− with a stoichiometry of
1Na+:1K+:2Cl−.
Due to this dual role it is difficult to predict whether a change
in the expression and in the activity of these transporters may
ameliorate or impair the susceptibility of cells to ischemia; for
example, enhanced Na+/H+ exchange would help to reduce the
intracellular pH but, on the other hand, it would promote cell
swelling and further Ca2+ influx throughNa+/Ca2+ exchange. In
particular, in cortical astrocyte cultures obtained from Na+/H+
exchanger isoform 1-deficient NHE1(-/-) mice the lack of NHE1
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attenuated the damage induced by conditionsmimicking cerebral
ischemia in vitro, and this effect was confirmed also in vivo
(Kintner et al., 2004). Indeed, the pharmacological blockade
of NHE-1 reduces infarct volume in animal models of brain
ischemia. In addition, ischemia/reperfusion causes an increase in
NHE-1 expression/activity (Ramasamy et al., 1995).
Although NHE activation is essential for the restoration
of physiological pHi, hyperactivation of NHE1 in neurons,
in response to the metabolic acidification associated with an
ischemic–hypoxic insult (Vornov et al., 1996; Luo et al., 2005;
Hwang et al., 2008; Kersh et al., 2009), disrupts the intracellular
ion balance, causing intracellular Na+ and Ca2+ overload
(Matsumoto et al., 2004), which eventually leads to cell death.
Consequently the in vitro and in vivo approach of several studies
have demonstrated neuroprotection with NHE inhibitors.
Similar data were obtained with genetic manipulations of
NKCC1 in mice and by the inhibition of NKCC1 using
bumetanide (Chen and Sun, 2005). NKCC1 is expressed in
neurons throughout the brain where it contributes to the
maintenance of [Cl−]i. Thus, it may affect neuronal excitability
by regulating [Cl−]i. Expression of NKCC1 protein has also
been found in astrocytes and oligodendrocytes (Lenart et al.,
2004). The pharmacological inhibition or transgenic ablation
of NKCC1 significantly attenuates infarction and swelling after
brain ischemia induced by transient middle cerebral artery
occlusion (tMCAO) (Chen and Sun, 2005). Therefore, it may
be hypothesized that NKCC1 represents an attractive target for
conditioning strategies against stroke.
NHE and NKCC Role during Ischemic
Preconditioning
NHE and NKCC role during ischemic preconditioning is still
controversial and very little is known about their role in the
processes triggered by brain preconditioning, since all the studies
were conducted in the heart. According to a first theory,
activation of both transporters participates in the protection
mediated by ischemic cardiac preconditioning. Indeed, the
reduced acidification occurring during ischemia (Schaefer et al.,
1995) along with the increase in intracellular sodium following
preconditioning is consistent with a modulation of these
proteins by preconditioning (Ramasamy et al., 1995). These
mechanisms may include the activation of both NKCC and NHE,
potentially resulting in reduced intracellular acidosis during
ischemia. NKCC regulation is multifactorial, with evidence
that the cotransporter is regulated by changes in cell volume
(O’Donnell, 1993) and cAMP-dependent (Pewitt et al., 1990;
Lytle et al., 1992; Klein, 1993) and non cAMP-dependent
protein phosphorylation as well as ionic concentration gradients.
Increased inward cotransporter flux during ischemia after
preconditioning could be beneficial in protecting the heart
through its functional coupling with the Cl−/HCO3− exchanger
(Anderson et al., 1990). In fact, chloride transported into the
cell by the Na+-K+-2Cl− cotransporter may exit via Cl−/HCO−3
exchange, thus increasing intracellular HCO3− and limiting
acidosis.
The primary factors regulating NHE include the intracellular
proton concentration and the phosphorylation state. Under
baseline conditions, the exchanger contributes to the
extracellular/intracellular proton gradient with net outward
transport of protons (Piwnica-Worms et al., 1986). Under
conditions of ischemia in which protons are generated and
intracellular pH decreases, the exchanger is stimulated to
increase extrusion of protons, thus increasing the inward
transport of sodium ions. However, this hypothesis has been
more recently disproved. In fact, it has been highlighted that
the above discussed study was carried out in hearts perfused
with a medium containing HCO3− and the method used to
induce acute intracellular acidosis resulted in greater acidosis
in preconditioned than in control hearts. For these reasons,
the faster initial recovery from acidosis in preconditioned
hearts may be a consequence of the lower starting pHi.
Indeed, de Albuquerque et al. (1995) recently showed that,
in a similar condition, the rate of pHi recovery is similar in
control and preconditioned rat hearts. More recently, it has
been demonstrated that NHE activity did not contribute to
the cardioprotection mediated by ischemic preconditioning.
Indeed, inhibition of Na+/H+ exchanger isoform-1 (NHE1)
is protective in adult myocardium in a model of ischemia
followed by reperfusion; however, the effect is unclear in
immature myocardium (Cun et al., 2007). More important, the
administration of HOE, a NHE inhibitor, did not prevent the
protection induced by preconditioning, thus suggesting that
NHE inhibition during the prolonged ischemic period may
enhance the protection afforded by preconditioning (Shipolini
et al., 1997). Accordingly, another group demonstrated that both
NHE inhibition and ischemic preconditioning eliminated the
increase in intramyocyte Na+ content that otherwise occurred
with cardioplegic arrest and reperfusion in a porcine model.
Because their mechanisms are distinct, the authors proposed
that an additive beneficial effect against ischemia-reperfusion
injury can be achieved by using NHE inhibition together with a
preconditioning stimulus as prereperfusion therapy (Goldberg
et al., 2002).
NHE and NKCC Role during Ischemic
Post-conditioning
Up until now, there is few information about the role
of NHE1 exchanger in brain post-conditioning since many
studies have demonstrated its neurodegenerative role in brain
ischemia upon activation. According to these data, the ischemic
neuroprotection induced by post-conditioning may be associated
with the downregulation of NHE1 expression or activity. These
hypothesis are supported by few experimental evidences. In this
regard, some information were obtained in the heart where it
has been demonstrated the role of NHE in a delayed recovery of
pHi after heart post-conditioning. Indeed, it has been suggested
that prolongation of acidosis during reperfusion is important
for the post-conditioning-mediated neuroprotection. Inserte
et al. demonstrated that such post-conditioning protocols that
significantly prolong pHi recovery during initial reperfusion are
protective for the heart. Accordingly, there is a narrow inverse
correlation between the level of the delay and the extent of cell
death, demonstrating the key role of the delay of intracellular
acidosis in the protection mediated by post-conditioning (Inserte
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et al., 2009). The normalization of pHi during reperfusion is
mediated by the combined action of different transport systems,
including Na+/H+-exchanger, Na+/HCO3− symport, and H+-
coupled lactate eﬄux (Vandenberg et al., 1993). These systems
appear to be mainly redundant, since inhibition of one of
them does not result in significant delay in pHi recovery. For
instance, inhibition of Na+/H+-exchanger by selective agents
administered at the onset of reperfusion has a very small effect
on pHi recovery (Docherty et al., 1997; Ten Hove and Van
Echteld, 2004). By contrast, simultaneous inhibition of Na+/H+-
exchanger and Na+/HCO3− symport delay normalization of pHi
(Docherty et al., 1997; Schäfer et al., 2000; Inserte et al., 2008).
The concept that pHi correction was correlated to the washout
of lactate, H+ and CO2 was supported by the strong correlation
between the delay in pHi recovery and the levels of lactate
measured in the coronary eﬄuent (blood outflow through
coronaries) during the first 2min of reperfusion (Vandenberg
et al., 1993; Inserte et al., 2008). Thus, reduced catabolite washout
caused an attenuation of the transmembrane H+ gradient and
a decreased activity of Na+/H+-exchanger and Na+/HCO3−
symport.
The protective effect of prolongation of intracellular acidosis
during reperfusion has been solidly demonstrated in different
models, including isolated cardiomyocytes (Schäfer et al., 2000)
and intact hearts (Kitakaze et al., 1988; Ohashi et al., 1996;
Preckel et al., 1998; Inserte et al., 2008). Intriguingly, there is a
correlation between delayed acidosis and other cardioprotective
pathways during post-conditioning such as Reperfusion Injury
Salvage Kinases (RISK) (Fujita et al., 2007). According to this
theory, alkalotic buffer reduced Akt and ERK phosporylation in
post-conditioned myocardium.
Regarding the role of Na+-dependent chloride transporter
(NKCC) during brain post-conditioning few information are
available. In a recent work it has been demonstrated that
in hippocampal neurons exposed to hypoxia conditioning
mimiking an in vitro post-conditioning, NKCC1 is strongly
activated through binding with STE20/SPS1-related
proline/alanine-rich kinase (SPAK) (Yang et al., 2013). This
finding could be considered as starting point for future studies.
Role of Acid-sensing Cation Channels (ASIC) in
Brain Conditioning
Acid-Sensing Ion Channels (ASICs) are neuronal voltage-
insensitive cationic channels activated by extracellular protons.
ASIC proteins are a subfamily of the ENaC/Deg superfamily
of ion channels. ASICs are potential drug targets for treating
a wide variety of conditions linked to both the CNS and
PNS. Acid-sensing cation channels (ASIC) have been extensively
studied both in physiological and in pathological conditions
for their wide distribution in the nervous system and since
they represent key targets in many different aspects of acidosis,
a condition that occurs during ischemic stroke, as previously
analyzed (Waldmann et al., 1997; Wemmie et al., 2006). Until
now, six ASIC subunit proteins, encoded by four genes, have
been identified: ASIC1a, ASIC1b, ASIC2a, ASIC2b, ASIC3,
and ASIC4; among these, the subtypes 1a, 2a, and 2b are
expressed in neurons of the CNS. All ASICs belong to the
degenerin/epithelial Na+ channel (DEG/ENaC) superfamily,
which are Na+- selective cation channels sensitive to amiloride
(Crowell and Kaufmann, 1961; Sutherland et al., 2000). Blockade
of ASIC1a and deletion of the ASIC1 gene rescued neurons
from ischemic cell death. In CNS neurons, ASIC1a responds
to extracellular pH reduction ranging from 6.9 to 5.0 to
generate rapid depolarizing currents (Waldmann et al., 1997),
and its activation enhances the probability of action potential
initiation (Vukicevic and Kellenberger, 2004). ASIC1a channels
are activated at the pH values associated with CNS diseases
(ischemia, ∼pH 6.5–6.0; seizure, ∼pH 6.8; AD, ∼pH 6.6). In
the case of homomeric ASIC1a channels, acid activation also
induces Ca2+ entry directly through these channels (Crowell and
Kaufmann, 1961; Nedergaard et al., 1991; Dietrich and Morad,
2010). In addition, the ASIC-mediated membrane depolarization
may facilitate the activation of voltage gated Ca2+ channels
and NMDA receptor-gated channels (Gao et al., 2005), further
promoting neuronal excitation and [Ca2+]i accumulation.
Acidosis usually occurs during many central nervous system
(CNS) diseases. Indeed, ischemic brain pH falls to 6.0 due to
the accumulation of lactic acid and to the protons produced by
ATP hydrolysis (Nedergaard et al., 1991; Gao et al., 2005). So the
reasonable strategy to contrast pH lowering, sustained by ASICs
activation, is to block its activity, since acidosis is a common
feature of acute neurological conditions such as ischemic stroke,
brain trauma, and epileptic seizures (Rehncrona, 1985). It is
rational to suggest that restoration of acid–base balance and
blockade of the down-stream pathways of acidosis may represent
two promising strategies to avoid the consequences of acidosis.
In this directionASIC involvement in neuroprotection elicited
in the brain by pre- and post-conditioning has been investigated
(Pignataro et al., 2007).
Indeed, Pignataro and colleagues demonstrated that ASIC1a
is downregulated during both preconditioning and post-
conditioning and that this downregulation was dependent on
p-Akt. Particularly, p-Akt is up-regulated during ischemic pre-
and post-conditioning. In fact, during harmful ischemia, Akt
is transiently phosphorylated, and then activated for a short
time interval after reperfusion (Beg et al., 2008), whereas
after brain conditioning the phosphorylation of Akt persists
longer, even 24 h later, the same time interval at which an
ASIC1a downregulation occurs. Interestingly, selective p-Akt
inhibition prevented ASIC1a downregulation thus reverting the
conditioning-induced neuroprotection.
That p-Akt is the mediator of the downregulation of ASIC1a
during pre- and post-conditioning are supported by previous
papers showing that Reperfusion Injury Salvage Kinasesì (RISKs),
including Akt (Nedergaard et al., 1991; Xu and Xiong, 2007;
Beg et al., 2008; Pignataro et al., 2011a) are activated during
conditioning. In conclusion, since reduction of ASIC1a is a key
factor in the neuroprotective effect of pre- and post-conditioning,
the downregulation of its expression and activity might
be a potential strategy to ameliorate the ischemic damage.
Besides ASIC1a, ASIC2a has also been linked to ischemic
preconditioning neuroprotection. In fact, the upregulation of
ASIC2a is associated to the neuroprotective effect of ischemic
preconditioning on global brain ischemia (Miao et al., 2010).
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Role of Sodium/Calcium Exchanger (NCX) during
Brain Conditioning
The sodium-calcium exchanger (Na+/Ca2+ exchanger, NCX,
or exchange protein) is an antiporter membrane protein that
removes calcium from cells. It consists of nine transmembrane
segments that can mediate Ca2+ and Na+ fluxes across
the plasma membrane. Depending on the intracellular
concentrations of Ca2+, [Ca2+]i, and Na
+, [Na+]i, NCX
can operate either in the forward mode, coupling the uphill
extrusion of Ca2+ to the influx of Na+ ions, or in the reverse
mode, mediating the extrusion of Na+ and the influx of the Ca2+
ions (Pignataro et al., 2004). The NCX is considered one of the
most important cellular mechanisms for removing Ca2+. The
maintenance of Na+ and Ca2+ homeostasis, mediated by this
exchanger, is a crucial physiological phenomenon in neuronal
and non-neuronal cells. NCX countertransports four or three
Na+ ions in change of one Ca2+ ion (Reeves and Hale, 1984;
Fujioka et al., 2000; Kang and Hilgemann, 2004); it is a high-
capacity and low-affinity ionic transporter. When intracellular
Ca2+ concentrations ([Ca2+]i) increase this exchanger mediates
the entrance of sodium ions and the extrusion of calcium
ions in tight dependence of their electrochemical gradient.
The way in which the antiporter works (forward or reverse)
depends on several factors such as membrane potential, Na+
and Ca2+ gradient. Therefore, NCX represents an important
actor in the regulation of pathophysiological and physiological
responses to increases of [Ca2+]i and [Na
+]i (Haddad and
Jiang, 1997; Dirnagl et al., 1999; Annunziato et al., 2004) In
particular, three distinct NCX genes, ncx1-3, and several splicing
variants have been so far described (Nicoll et al., 1990, 1996).
The CNS is the only organ that expresses all three NCX gene
products. NCX is particularly expressed in neurons at the level of
synapses (Canitano et al., 2002) where, in the course of an action
potential, Ca2+ crosses the plasma membrane. Calcium entry
allows the fusion of synaptic vesicles with the plasmamembrane
and permits the neurotransmitter release. After that, plasma
membrane Ca2+ ATPase and NCX mediate the extrusion of the
residual intracellular Ca2+. In presence of [Ca2+]i higher than
500 nM, NCX become the prevalent Ca2+ extrusion mechanism
(Pignataro et al., 2014). At the same time, the deregulation
of [Ca2+]i and [Na
+]i homeostasis may mediate the damage
of neuronal and glial cells occurring after stroke and other
neurodegenerative disorders.
Na+/Ca2+ Exchanger in Brain Preconditioning
It is well-known that NCX may play a role in the maintenance
of ionic homeostasis during ischemic conditioning (Pignataro
et al., 2004, 2012; Molinaro et al., 2013). In this respect, NCX is
downregulated during brain ischemia and this downregulation
occurs in a manner dependent on the exchanger isoform and
on the brain region interested by the damage (Pignataro et al.,
2004; Boscia et al., 2006). It has been recently demonstrated
that NCX1 and NCX3 isoforms represent two new effectors
of the preconditioning-mediated neuroprotection (Pignataro
et al., 2012). In fact, while the absence of NCX1 and NCX3
is able to partially prevent the neuroprotection mediated
by ischemic preconditioning, the pro-survival factor p-Akt
mediated preconditioning-induced brain protection by inducing
an upregulation of NCX1 and NCX3. In this field, these results
have been obtained in an experimental model of ischemic
preconditioning in which preconditioning was mediated in rats
by 30min occlusion of the middle cerebral artery (MCA),
followed by a subsequent harmful stimulus of 100min of
MCA occlusion, applied 72 h after the preconditioning stimulus
(Pignataro et al., 2012). The correlation between NCX and p-
Akt was demonstrated also by confocal fluorescence experiments,
that showed a colocalization among NCX1, NCX3, and p-Akt
in the temporoparietal cortex of preconditioned rats (Formisano
et al., 2008; Pignataro et al., 2012). Moreover, the PI3-K inhibitor,
LY294002, reverts the protective outcome elicited by ischemic
preconditioning, thus giving further support to the role of
p-Akt in this phenomenon (Endo et al., 2006; Pignataro et al.,
2008). The overexpression p-Akt-dependent of NCX1 and NCX3
elicited by brain preconditioningmay be considered a response of
cells to overcome the deregulation of ionic homeostasis occurring
in the brain under anoxic conditions. On the other hand, p-Akt
is not the only transducer able to activate NCX1 and NCX3.
Indeed, Valsecchi and colleagues underlineed that after ischemic
preconditioning, hypoxia-inducible factor, HIF-1α, is strongly
increased and mediated the increased expression of NCX1
expression, thus contributing to brain protection induced by
ischemic preconditioning (Valsecchi et al., 2011) and suggesting
that ncx1 gene represents a new HIF-1 target (Valsecchi et al.,
2011). Summarizing, NCX1 and NCX3 overexpression may
be considered as a mechanism that preconditioning activates
in neurons and glial cellsin order to overcome the loss of
ionic homeostasis caused by harmful ischemia. Interestingly, the
activation of these mechanisms are long lasting, since NCX1 and
NCX3 upregulation is still present 72 h after preconditioning
induction, thus suggesting that these two isoforms can be
included in the list of effectors able to mediate the so-called
delayed preconditioning (Pignataro et al., 2013a).
Na+/Ca2+ Exchanger in Brain Post-conditioning
Regarding NCX role during brain post-conditioning, NCX3
has been confirmed as a molecular effector involved in
the neuroprotection (Pignataro et al., 2011b). In particular,
interesting results have been obtained in an experimental model
of ischemic post-conditioning, performed in the laboratory of
Pignataro and colleagues by subjecting adult male rats to 10min
of MCAO 10min after 100min of MCAO. Results showed
that p-Akt expression after post-conditioning increased and
timely mirrors the increase in NCX3 expression. On the other
hand, NCX3 silencing reverted the post-conditioning-mediated
neuroprotection and the selective inhibition of p-Akt prevented
NCX3 upregulation and the neuroprotection (Pignataro et al.,
2011b). NCX3 overexpression during post-conditioning may
contribute to counteract the ionic homeostasis dysregulation. By
contrast NCX1 silencing did not revert the post-conditioning-
induced neuroprotection, thus showing that NCX1 does not
play a relevant role during post-conditioning. This result can
be explained by the observation that unlike NCX1 and NCX2,
the isoform NCX3 may be still operative during ATP depletion
(Linck et al., 1998; Secondo et al., 2007). In addition, the
Frontiers in Neuroscience | www.frontiersin.org 7 August 2015 | Volume 9 | Article 277
Cuomo et al. Ionic homeostasis in brain conditioning
differences in NCX1 and NCX3 promoters render NCX3 a
better target for the prosurvival kinase cAMP response element-
binding protein (CREB), an Akt downstream player (Gabellini
et al., 2003). After post-conditioning, the phosphorylation of Akt
is present longer (Pignataro et al., 2008) and timely parallels
the intervals of NCX3 upregulation. Furthermore, confocal
experiments in the temporoparietal confirmed that the increased
expression of these two proteins after post-conditioning occurs
in the same cells. These considerations, beside showing that p-
Akt palys a key role in neuroprotection, more important suggest
NCX3 as one of the additional p-Akt effectors involved in the
neuroprotective effect of ischemic post-conditioning.
Role of Plasma Membrane Ca2+ ATPase (PMCA)
in Brain Conditioning
The plasma membrane Ca2+ ATPase (PMCA) is a transport
protein in the plasma membrane of cells that functions removing
calcium (Ca2+) from the cell; so it is also an important
regulator of the calcium concentration in the extracellular space.
This protein is the only plasmamembrane high affinity Ca2+
transporting system. It removes Ca2+ from the cytosol in all
eukaryotic cells, and for most of them it is the only Ca2+
exporting system together with Na+/Ca2+ exchanger which
represent the principal Ca2+ exchanger in heart cells and
neurons (Jensen et al., 1993). The high Ca2+ affinity of the
pump, however renders it the only system capable of fine-
tuning its exchanges with the external ambient (Brini et al.,
2013).
Conversely to other plasma membrane buffering systems,
such as NCX and ATPases, plasmamembrane Ca2+ -ATPasemay
export intracellular Ca2+ even with relatively lower transport
capacity during prolonged membrane hyperpolarization and
during conditions of increased intracellular Na+ concentrations,
as occurred under ischemic conditions. Ohta et al. (1996)
suggested that ischemia-tolerant CA1 neurons, in a model of
bilateral common carotid arteries occlusion in gerbils, export
more efficiently a larger amount of Ca2+ (Kato et al., 2005).
Moreover, in gerbils, ischemic preconditioning by pre-
exposure to 2-min ischemia is extremely effective in protecting
against ischemic cell death since there is a modification of the
electrophysiological properties of CA1 neurons (Kawai et al.,
1998; Shimazaki et al., 2000). In this experimental conditions,
expression of PMCA1 is increased in the hippocampus following
2-min ischemia (Kato et al., 2005). The same authors evaluated
PMCA1 expression also in a model of tolerance induced by
a low dose treatment with 3-Nitro Propionic Acid (3-NPA).
They observed an increase in the expression of Bcl-2 in the
hippocampus in both the models of preconditioning. However,
PMCA1 increased just in the 2-min ischemia model and not in
the 3-NPA model, thus suggesting that it plays an important but
not essential role in the enhancement of ischemic tolerance (Kato
et al., 2005).
Conclusions
The identification of the players involved in the control of ionic
homeostasis during pre and post-conditioning should provide
more direct opportunities for translational neuroprotection
trials. Indeed, the present review, summarizing the specific
effect of the plasmamembrane proteins involved in the
maintenance of cellular ionic concentration, would provide
information of which transporters needed to be activated
or inhibited in order to protect the brain by the ischemic
injury.
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